About
Microbiome-related diseases, diagnostics
Areas of Focus
Categories
DiagnosticsMicrobiome
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
536
By Phase
PHASE1/PHASE2: 4PHASE2: 1PHASE1: 2NA: 2
By Status
TERMINATED: 4COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT05589597Lead Sponsor
EO4010 in Previously Treated Metastatic Colorectal Carcinoma
PHASE1/PHASE2Terminated
25 participants
Started: Jun 1, 2023 · Completed: May 30, 2025
NCT05350501Lead Sponsor
EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Cancer
PHASE2Terminated
1 participants
Started: Mar 1, 2023 · Completed: Jan 23, 2024
NCT04669171Lead Sponsor
A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
PHASE1/PHASE2Recruiting
60 participants
Started: Jul 5, 2021 · Completed: May 30, 2032
NCT04187404Lead Sponsor
A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
PHASE1/PHASE2Terminated
70 participants
Started: Jul 23, 2020 · Completed: Oct 2, 2024
NCT04116658Lead Sponsor
First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma
PHASE1/PHASE2Completed
100 participants
Started: Jul 13, 2020 · Completed: Mar 4, 2024
Locations (1)
Headquarters
Evry, France
Map
Loading map...